Promising treatment for Alexander disease moves from rat model to human clinical trials

Alexander disease is a progressive and rare neurological disorder with no cure or standard course of treatment. But a new study led by researchers at the University of Wisconsin–Madison involving a rat model of the disease offers a potential treatment for the typically fatal condition.

Janet E. Lainhart honored with AACAP George Tarjan Award

The American Academy of Child and Adolescent Psychiatry (AACAP) has awarded Janet E. Lainhart, MD, a pediatrician, psychiatrist, professor in the School of Medicine and Public Health at the University of Wisconsin-Madison, and a Waisman Center investigator, the 2021 AACAP George Tarjan, MD, Award for Contributions in Developmental Disabilities.

Studying the connection between Alzheimer’s and Down syndrome for Down syndrome awareness month

By Emily Leclerc, Waisman Science Writer The month of October is Down Syndrome Awareness Month and is dedicated to not only raising awareness about Down syndrome but also to celebrating the abilities and accomplishments of …

Stem cell project to create new model to study brain development and Down syndrome

Waisman Center researchers are creating a new approach to study how changes to brain development in the womb result in intellectual disability in people with Down syndrome.

UW-Madison is key site on landmark study focused on early childhood brain development and the impact of substance abuse and stress in infants and young children

The University of Wisconsin-Madison will be one of 25 sites to study early brain and behavior development and the impact of early exposure to substances – such as opioids – and social stressors in infants and young children.